Research roundup: diagnostic and prognostic cancer markers
Interested in seeing more of our cancer research antibodies in action? The following three studies have successfully utilized different Atlas Antibodies products to suggest or identify new biomarkers for different cancers.
Research Roundup: prognostic biomarkers in cancer
Many of our cancer antibodies are used in cutting-edge research to identify new prognostic markers in different cancers. Let's take a look at three recent studies.
Interview with a scientist: drug repurposing in oncology
Drug repurposing is the strategy of using existing drugs originally developed for a specific disease to treat other diseases. We have interviewed Dr. Joanna Zawacka-Pankau about her research in drug repurposing to treat cancer.
Liquid biopsy: what is written in the blood?
Liquid biopsy is a non-invasive sampling approach also used to predict the progression and growth dynamics of cancer and provide guidance for therapy monitoring. This blog covers various features and issues associated with liquid biopsy as exemplified by tumor markers.
Candidate diagnostic biomarkers for lung cancer
In this blog, we discuss the rapidly evolving field of targeted drug therapy in lung cancer.
Keep reading to learn more!
Cancer research highlights from AACR 2019
From Atlanta, Dr. Kristian Moller, Principal Scientist at Atlas Antibodies, shares the top research highlights from the Annual American Advancement for Cancer Research meeting (AACR) 2019.
The Pathology Atlas - a discovery journey in cancer research
The Pathology Atlas is an open-access database for the identification of genes, RNA, proteins, and metabolites in human cancerous tissues and organs. Read more!